1. Myeloid‐derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes
   Sílvia Casacuberta‐Serra et al, 2017, Immunology & Cell Biology CrossRef
2. Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis
   Young Hun Chung et al, 2023, Proceedings of the National Academy of Sciences CrossRef
3. Future Direction of Cancer Neuroscience
   Jami L. Saloman et al, 2023, Cancer Neuroscience CrossRef
4. Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells
   WeiHong Ren et al, 2020, Scientific Reports CrossRef
5. Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer
   Y. Li et al, 2021, Clinical and Translational Oncology CrossRef
6. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment
   Eric Jou et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
7. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
   Mahmoud Mohammad Yaseen et al, 2020, Open Biology CrossRef
8. Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment
   Rosalia Busà et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
9. The Role of CXC Chemokines in Cancer Progression
   Tiantian Wu et al, 2022, Cancers CrossRef
10. Differentiation of Murine Myeloid-Derived Suppressor Cells
    David Escors, 2016, Myeloid-Derived Suppressor Cells and Cancer CrossRef
11. Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression
    Jia-Nan Cheng et al, 2021, Frontiers in Cell and Developmental Biology CrossRef